LLY earnings: real EPS beat/miss history, analyst consensus Buy, P/E 41.24. Updated 2026-07-23.
Eli Lilly and (LLY) Research Hub
Eli Lilly and (LLY) trades on NYSE, US in the Healthcare (Drug Manufacturers - General) sector. As of 2026-09-11, shares last closed at 1,115.25 USD (-0.80%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 41.24, market cap 1094.51B. This hub links to the full technical, earnings and options research available for LLY.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - General) |
|---|---|
| Exchange | NYSE, US |
| Last close | 1,115.25 USD (-0.80%) |
| 52-week range | 1,093.15 USD – 1,292.65 USD |
| Trend regime | Range |
| 14-day RSI | 39.1 (Bearish) |
| Trailing P/E | 41.24 |
| Market cap | 1094.51B |
| Dividend yield | 0.56% |
Available research for LLY
Covered Call on LLY: how it works, illustrative setup around the real 1,115.25 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on LLY: how it works, illustrative setup around the real 1,115.25 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on LLY: how it works, illustrative setup around the real 1,115.25 USD price, max profit/loss, breakeven and when to use it. Educational.
LLY technical analysis: range, last 1,115.25 USD, RSI 39.1, 52w range 1,093.15 USD–1,292.65 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is LLY in?
Eli Lilly and (LLY) is classified under Healthcare (Drug Manufacturers - General), listed on NYSE, US.
Is LLY in an uptrend or downtrend?
As of 2026-09-11, LLY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is LLY's trailing P/E ratio?
LLY's trailing P/E is 41.24, with a market cap of 1094.51B. See the earnings research page for full valuation detail.